The Safety and Tolerability of Newer Antiepileptic Drugs in Children and Adolescents
Childhood epilepsy continues to be intractable in more than 25% of patients diagnosed with epilepsy. The introduction of new anti-epileptic drugs (AEDs) provides more options for treatment of children with epilepsy. We review the safety and tolerability of seven new AEDs (levetiracetam, lamotrigine,...
Main Authors: | Kayani, Saima, Sirsi, Deepa |
---|---|
Format: | Online |
Language: | English |
Published: |
Libertas Academica
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619554/ |
Similar Items
-
Hypersensitivity to antiepileptic drugs in children
by: Atanaskovic-Markovic, Marina, et al.
Published: (2014) -
Systematic Adverse Drug Reaction Monitoring of Patients Under Newer Antiepileptic Drugs Using Routine Clinical Data of Inpatients
by: Hilgers, Annika, et al.
Published: (2016) -
Pharmacovigilance of antiepileptic drug toxicity in children
by: Egunsola, Oluwaseun
Published: (2017) -
Antiepileptic Drug Treatment in Children with Epilepsy
by: Rosati, Anna, et al.
Published: (2015) -
The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review
by: de Jong, Josta, et al.
Published: (2016)